Copyright
©2014 Baishideng Publishing Group Inc.
World J Transplant. Sep 24, 2014; 4(3): 206-215
Published online Sep 24, 2014. doi: 10.5500/wjt.v4.i3.206
Published online Sep 24, 2014. doi: 10.5500/wjt.v4.i3.206
Figure 2 Model for End-Stage Liver Disease subgroups.
A: Percentage of patients remaining waitlisted at initial Model for End-Stage Liver Disease over time; B: Analysis of patient movement between subgroups for those remaining waitlisted at 90 d. MELD: Model for End-Stage Liver Disease.
- Citation: Halldorson JB, Jr RLC, Bhattacharya R, Bakthavatsalam R, Liou IW, Dick AA, Reyes JD, Perkins JD. D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation. World J Transplant 2014; 4(3): 206-215
- URL: https://www.wjgnet.com/2220-3230/full/v4/i3/206.htm
- DOI: https://dx.doi.org/10.5500/wjt.v4.i3.206